Related Experiment Video
Updated: Jul 7, 2026

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection
Published on: January 31, 2020
PRO-2000, an antimicrobial gel for the potential prevention of HIV infection
Patricia S Fletcher1, Robin J Shattock
1St George's University of London, Cranmer Terrace, London, SW17 0RE, UK. pfletche@sgul.ac.uk
Abstract:
Indevus Pharmaceuticals Inc, under license from Paligent Inc, is developing PRO-2000, an antimicrobial gel for the prevention of HIV infection. The company is also investigating its potential to prevent the transmission of other sexually transmitted diseases. In February 2005, Indevus launched a pivotal phase III trial for the prevention of HIV infection in women. At that time, further phase III trials in 12,000 African women were scheduled to begin in 2005. A second phase III trial began for the prevention of sexually transmitted infections, including HIV, herpes, Chlamydia and gonorrhea, in Africa in October 2005.
More Related Videos
12:21Fabrication and Characterization of Griffithsin-modified Fiber Scaffolds for Prevention of Sexually Transmitted Infections
Published on: October 31, 2017
07:22A High-throughput Cre-Lox Activated Viral Membrane Fusion Assay to Identify Inhibitors of HIV-1 Viral Membrane Fusion
Published on: August 14, 2018
Related Concept Videos
Inhibitors of Virion Maturation and Assembly
Antiprotozoal Agents
Genital Herpes
Antimicrobial Effectiveness
Inhibitors Of Virion Release
Antiviral Nucleoside Inhibitors